Sort
48,018 grants matching “immunotherapy”
Collagen Binding MSCRAMMs
$419,265Texas A&M University Health Science Ctr · R01 · FY2003 · AR
Using dietary glutamine supplementation for melanoma prevention and targeted therapy
$419,220Mei Kong · University Of California-Irvine · R01 · FY2022 · CA
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
$419,207Yibin Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA
Role of IKK alpha in lymphoid organ development
$419,198Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Targeting mechanisms of immune evasion in chemotherapy-induced senescent cells
$419,189James Jackson · Tulane University Of Louisiana · R01 · FY2023 · CA
Induction of Tumor Immunity by Secreted HSP-gp96
$419,167Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2007 · CA
Structure and Function of Heme-based Dioxygenases
$419,166Syun-Ru Yeh · Albert Einstein College Of Medicine · R01 · FY2020 · GM
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$419,152John H Sampson · Duke University · R01 · FY2014 · NS
Human Monoclonal Antibodies against Botulinum Toxins
$419,084Kim D Janda · Scripps Research Institute, The · U01 · FY2007 · AI
Leveraging combination histotripsy tumor ablation and N-dihydrogalactochitosan immunostimulation to advance osteosarcoma therapy
$419,080Joanne Tuohy · Virginia Polytechnic Inst And St Univ · R21 · FY2025 · CA
Developmental Funds
$419,048Helen E Heslop · Baylor College Of Medicine · P30 · FY2023 · CA
Developmental Funds
$419,048C Kent Osborne · Baylor College Of Medicine · P30 · FY2020 · CA
Developmental Funds
$419,048Helen E Heslop · Baylor College Of Medicine · P30 · FY2024 · CA
Developmental Funds
$419,048Helen E Heslop · Baylor College Of Medicine · P30 · FY2022 · CA
Targeting TREM2 to boost anti-cancer therapy
$419,032Marco Colonna · Washington University · R01 · FY2024 · CA
DPT-1 / TrialNet
$418,999University Of Colorado Denver · U01 · FY2005 · DK
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
$418,946Vu Nguyen Ngo · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Potentiating Anti-WT1 responses by Targeting Peptide/MHC Complexes with T
$418,930David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
Immune surveillance in murine gammaherpesvirus infection
$418,918Edward John Usherwood · Dartmouth College · R01 · FY2010 · CA
Impact of senescence on T-cell function and immunotherapeutic response
$418,905Christin E Burd · Ohio State University · R01 · FY2019 · AG
Impact of senescence on T-cell function and immunotherapeutic response
$418,905Christin E Burd · Ohio State University · R01 · FY2018 · AG
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma
$418,885Michael Richard Green · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention
$418,872Ruth Lupu · Northshore University Healthsystem · R01 · FY2007 · CA
Cell migration and virological synapse formation in parenteral HIV transmission
$418,857Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · DA
Combining AD epitope vaccine with innate immunity
$418,833University Of California Irvine · R01 · FY2005 · NS